• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症通过下调阿霉素肾病小鼠肾脏 PCSK9 诱导肾脏脂质沉积。

Inflammation Induces Lipid Deposition in Kidneys by Downregulating Renal PCSK9 in Mice with Adriamycin-Induced Nephropathy.

机构信息

Key Laboratory of the Ministry of Education, Key Laboratory of Child Development and Disorders, Key Laboratory of Pediatrics in Chongqing, Chongqing International Science and Technology Cooperation Center for Child Development and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China (mainland).

Department of Nephrology, Children's Hospital of Chongqing Medical University, Chongqing, China (mainland).

出版信息

Med Sci Monit. 2019 Jul 18;25:5327-5335. doi: 10.12659/MSM.917312.

DOI:10.12659/MSM.917312
PMID:31317882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6659460/
Abstract

BACKGROUND Previous studies of human and animal models indicate that inflammation alters lipid metabolism. The pro-protein convertase subtilisin kexin type 9 (PCSK9) plays an important role in lipid metabolism. MATERIAL AND METHODS We examined the effect of inflammation on PCSK9 expression and lipid deposition in the kidneys of mice with Adriamycin-induced nephropathy. RESULTS The results indicated an increased expression of inflammatory cytokines and lipid deposition over 12 weeks. During this time, the expression of PCSK9 and its transcriptional activator (hepatocyte nuclear factor 1alpha, HNF1alpha) decreased, and the expression of the low-density lipoprotein receptor (LDLR) and its transcriptional activator (sterol regulatory element binding protein-2, SREBP-2) increased. Exogenous inflammation appeared to further aggravate this process. CONCLUSIONS Our mouse model of nephropathy suggests that a key step in the inflammation-induced deposition of lipids in the kidneys is the downregulation renal PCSK9 expression.

摘要

背景

先前的人体和动物模型研究表明,炎症会改变脂质代谢。前蛋白转化酶枯草溶菌素 9(PCSK9)在脂质代谢中发挥着重要作用。

材料与方法

我们研究了炎症对阿霉素诱导肾病小鼠肾脏中 PCSK9 表达和脂质沉积的影响。

结果

结果表明,炎症因子的表达增加和脂质沉积在 12 周内增加。在此期间,PCSK9 及其转录激活物(肝细胞核因子 1α,HNF1α)的表达降低,而低密度脂蛋白受体(LDLR)及其转录激活物(固醇调节元件结合蛋白-2,SREBP-2)的表达增加。外源性炎症似乎进一步加重了这一过程。

结论

我们的肾病小鼠模型表明,炎症诱导肾脏脂质沉积的关键步骤是下调肾脏 PCSK9 的表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4021/6659460/6b4988a5e9a5/medscimonit-25-5327-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4021/6659460/6335a2802d31/medscimonit-25-5327-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4021/6659460/ba78b7750074/medscimonit-25-5327-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4021/6659460/c9ec5d478ae1/medscimonit-25-5327-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4021/6659460/b34caa19b8ad/medscimonit-25-5327-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4021/6659460/6b4988a5e9a5/medscimonit-25-5327-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4021/6659460/6335a2802d31/medscimonit-25-5327-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4021/6659460/ba78b7750074/medscimonit-25-5327-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4021/6659460/c9ec5d478ae1/medscimonit-25-5327-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4021/6659460/b34caa19b8ad/medscimonit-25-5327-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4021/6659460/6b4988a5e9a5/medscimonit-25-5327-g005.jpg

相似文献

1
Inflammation Induces Lipid Deposition in Kidneys by Downregulating Renal PCSK9 in Mice with Adriamycin-Induced Nephropathy.炎症通过下调阿霉素肾病小鼠肾脏 PCSK9 诱导肾脏脂质沉积。
Med Sci Monit. 2019 Jul 18;25:5327-5335. doi: 10.12659/MSM.917312.
2
Chitosan oligosaccharides enhance lipid droplets via down-regulation of PCSK9 gene expression in HepG2 cells.壳寡糖通过下调 HepG2 细胞中 PCSK9 基因的表达来增加脂滴。
Exp Cell Res. 2018 May 15;366(2):152-160. doi: 10.1016/j.yexcr.2018.03.013. Epub 2018 Mar 14.
3
Enhanced pro-protein convertase subtilisin/kexin type 9 expression by C-reactive protein through p38MAPK-HNF1α pathway in HepG2 cells.C反应蛋白通过p38丝裂原活化蛋白激酶-HNF1α途径增强HepG2细胞中前蛋白转化酶枯草杆菌蛋白酶/kexin 9型的表达。
J Cell Mol Med. 2016 Dec;20(12):2374-2383. doi: 10.1111/jcmm.12931. Epub 2016 Sep 15.
4
Alginate oligosaccharide enhances LDL uptake via regulation of LDLR and PCSK9 expression.海藻酸寡糖通过调节低密度脂蛋白受体(LDLR)和前蛋白转化酶枯草溶菌素9(PCSK9)的表达增强低密度脂蛋白(LDL)摄取。
J Nutr Biochem. 2015 Nov;26(11):1393-400. doi: 10.1016/j.jnutbio.2015.07.009. Epub 2015 Jul 30.
5
Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.针对枯草溶菌素转化酶 9 治疗血脂异常和动脉粥样硬化。
J Am Coll Cardiol. 2013 Oct 15;62(16):1401-8. doi: 10.1016/j.jacc.2013.07.056. Epub 2013 Aug 21.
6
Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9).白藜芦醇苷通过下调前蛋白转化酶枯草杆菌蛋白酶/九型酪蛋白激酶(PCSK9)改善2型糖尿病患者的脂质和葡萄糖代谢。
Cardiovasc Diabetol. 2016 Feb 1;15:19. doi: 10.1186/s12933-015-0325-x.
7
Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.脂联素受体的激活调节前蛋白转化酶枯草溶菌素/克新9型的表达并抑制载脂蛋白E缺陷小鼠的病变。
Arterioscler Thromb Vasc Biol. 2017 Jul;37(7):1290-1300. doi: 10.1161/ATVBAHA.117.309630. Epub 2017 May 25.
8
Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.Idol 在肝脏中的过表达通过两种机制:固醇调节元件结合蛋白 2 和低密度脂蛋白受体依赖性途径,增加了小鼠和仓鼠的循环蛋白转化酶枯草溶菌素/凝血酶 9。
Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1171-8. doi: 10.1161/ATVBAHA.113.302670. Epub 2014 Mar 27.
9
Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism.利拉鲁肽通过依赖 HNF-1a 的机制下调 HepG2 细胞和 db/db 小鼠肝脏 LDL 受体和 PCSK9 的表达。
Cardiovasc Diabetol. 2018 Apr 4;17(1):48. doi: 10.1186/s12933-018-0689-9.
10
Curcumin enhances cell-surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells.姜黄素通过下调 HepG2 细胞 PCSK9 基因表达来提高细胞表面 LDLR 水平并促进 LDL 摄取。
Mol Nutr Food Res. 2014 Nov;58(11):2133-45. doi: 10.1002/mnfr.201400366. Epub 2014 Sep 19.

引用本文的文献

1
Omega-3 supplementation attenuates doxorubicin-induced cardiotoxicity but is not related to the ceramide pathway.补充ω-3可减轻阿霉素诱导的心脏毒性,但与神经酰胺途径无关。
Food Sci Nutr. 2024 Sep 29;12(11):9198-9211. doi: 10.1002/fsn3.4492. eCollection 2024 Nov.
2
The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease.载脂蛋白 C-III 在心肾疾病中的作用及其调控机制
Diabetologia. 2024 Sep;67(9):1980-1997. doi: 10.1007/s00125-024-06191-8. Epub 2024 Jun 15.
3
The Emerging Roles of Intracellular PCSK9 and Their Implications in Endoplasmic Reticulum Stress and Metabolic Diseases.

本文引用的文献

1
CD36 Promotes Podocyte Apoptosis by Activating the Pyrin Domain-Containing-3 (NLRP3) Inflammasome in Primary Nephrotic Syndrome.CD36 通过激活原发性肾病综合征中的 Pyrin 结构域包含蛋白 3(NLRP3)炎症小体促进足细胞凋亡。
Med Sci Monit. 2018 Sep 27;24:6832-6839. doi: 10.12659/MSM.909810.
2
Nephrotic Syndrome with Thrombocytopenia, Lymphadenopathy, Systemic Inflammation, and Splenomegaly.伴有血小板减少、淋巴结病、全身炎症和脾肿大的肾病综合征。
Intern Med. 2018 Apr 15;57(8):1123-1129. doi: 10.2169/internalmedicine.9556-17. Epub 2017 Dec 21.
3
Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.
细胞内前蛋白转化酶枯草溶菌素9的新作用及其在内质网应激和代谢性疾病中的意义。
Metabolites. 2022 Feb 26;12(3):215. doi: 10.3390/metabo12030215.
4
MAMs Protect Against Ectopic Fat Deposition and Lipid-Related Kidney Damage in DN Patients.MAMs 可预防 DN 患者异位脂肪沉积和与脂质相关的肾脏损害。
Front Endocrinol (Lausanne). 2021 Feb 19;12:609580. doi: 10.3389/fendo.2021.609580. eCollection 2021.
5
Coming Back to Physiology: Extra Hepatic Functions of Proprotein Convertase Subtilisin/Kexin Type 9.回归生理学:前蛋白转化酶枯草杆菌蛋白酶/克新蛋白酶9型的肝外功能
Front Physiol. 2020 Dec 7;11:598649. doi: 10.3389/fphys.2020.598649. eCollection 2020.
肾病综合征中的血脂异常:机制与治疗
Nat Rev Nephrol. 2018 Jan;14(1):57-70. doi: 10.1038/nrneph.2017.155. Epub 2017 Nov 27.
4
SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology.SREBP 调控的脂质代谢:趋同的生理学-不同的病理生理学。
Nat Rev Endocrinol. 2017 Dec;13(12):710-730. doi: 10.1038/nrendo.2017.91. Epub 2017 Aug 29.
5
Successful treatment of a patient with refractory nephrotic syndrome with PCSK9 inhibitors: a case report.使用前蛋白转化酶枯草溶菌素9(PCSK9)抑制剂成功治疗一名难治性肾病综合征患者:病例报告
BMC Nephrol. 2017 Jul 6;18(1):221. doi: 10.1186/s12882-017-0644-0.
6
Focal Segmental Glomerulosclerosis.局灶节段性肾小球硬化症
Clin J Am Soc Nephrol. 2017 Mar 7;12(3):502-517. doi: 10.2215/CJN.05960616. Epub 2017 Feb 27.
7
PCSK9 in chronic kidney disease.慢性肾脏病中的前蛋白转化酶枯草溶菌素9
Int Urol Nephrol. 2017 Jun;49(6):1015-1024. doi: 10.1007/s11255-017-1505-2. Epub 2017 Jan 13.
8
Enhanced pro-protein convertase subtilisin/kexin type 9 expression by C-reactive protein through p38MAPK-HNF1α pathway in HepG2 cells.C反应蛋白通过p38丝裂原活化蛋白激酶-HNF1α途径增强HepG2细胞中前蛋白转化酶枯草杆菌蛋白酶/kexin 9型的表达。
J Cell Mol Med. 2016 Dec;20(12):2374-2383. doi: 10.1111/jcmm.12931. Epub 2016 Sep 15.
9
Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.肾病综合征中的脂质代谢紊乱:机制与后果
Kidney Int. 2016 Jul;90(1):41-52. doi: 10.1016/j.kint.2016.02.026. Epub 2016 Apr 26.
10
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia.前蛋白转化酶枯草溶菌素 9(PCSK9)与代谢综合征:对胰岛素抵抗、炎症和致动脉粥样硬化性血脂异常的新认识。
Endocrine. 2016 Dec;54(3):588-601. doi: 10.1007/s12020-016-0939-0. Epub 2016 Apr 1.